Acquiring VitalConnect could unlock a $1 billion cardiac monitoring market that is only partly served by iRhythm’s existing ...
Upon closing, combination immediately broadens iRhythm's ambulatory cardiac monitoring portfolio, including in the large and growing mobile cardiac telemetry category, and adds continuous multi-vitals ...
Health technology company Philips has introduced a new telemetry platform to address the challenge of staffing shortages and alarm management. A key feature is Telemetry Monitor 5500, a "data-driven ...
Medical Device Network on MSN
Philips broadens patient monitoring capabilities with six new partnerships
Philips' new partnerships are intended to advance its patient monitoring ecosystem's out-of-hospital monitoring provision.
Medical Device Network on MSN
iRhythm advances cardiac monitoring provision with $287.5M VitalConnect acquisition
IRhythm announced the deal alongside its Q2 financials in which its revenues rose 20.1% YoY.
A suite of sensors, such as 1-lead ECG, SPO2, temperature, BP, and weight scale, that can be used by the patients at home and transmit their vital signs and other measurements to the cloud in ...
August 6, 2026New collaborations expand wearable and out-of-hospital monitoring capabilities, helping support continuous patient visibility from ...
Big news for the first startup shepherded by the West Wireless Health Institute: The FDA has greenlit Corventis' Nuvant system, a mobile cardiac telemetry system. The 510(k) clearance for Nuvant ...
Findings published in the American Heart Journal show higher clinical diagnostic yield and lower odds of retesting with Zio long-term continuous monitoring service (LTCM) compared to other LTCM and ...
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities ...
Experts discuss how choosing the right cardiac rhythm monitor involves balancing symptom frequency, patient risk, and device capabilities to ensure efficient, cost-effective, and patient-centered ...
SAN FRANCISCO, Jan. 05, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC) today announced that the results from the Cardiac Ambulatory Monitor EvaLuation of Outcomes and Time to Events (CAMELOT) study have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results